Form 4 for NVCR NovoCure Ltd
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-29 · accession 0001562180-25-005572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-30 | 2025-07-29 | NVCR | Brackmann Christoph | CFO | P - Purchase | $11.59 | +20.0K | 136.2K | +17% | +$231.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-07-29 | P | A | 10,000 | $11.63 | 131,150 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-07-29 | P | A | 5,000 | $11.50 | 141,150 | D | — | — | |
| 3 | Common | Ordinary Shares | 2025-07-29 | P | A | 5,000 | $11.60 | 136,150 | D | — | — |